Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker.
Already partnered on beta thalassemia and sickle cell disease (SCD), Vertex Pharmaceuticals Incorporated and CRISPR Therapeutics AG revealed on 27 March that they are teaming up again, this...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?